The prevention of medication errors is an essential requirement for pharmaceutical care and must be a core mission of every pharmacy. If efforts to prevent medication errors are to be effective and successful, they must become a priority.
MARCH, 2009

Venous thromboembolism (VTE), comprised of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a major cause of death, disability, and economic burden worldwide. VTE afflicts millions of individuals and accounts for several hundred thousand deaths annually in the United States.
FEBRUARY, 2009

For all of the immune globulin (Ig) products produced in the United States, there are only 5 FDA-approved indications. The most recent approval was in September 2008 for chronic inflammatory demyelinating polyneuropathy (CIDP) for Gamunex (Talecris).
JANUARY, 2009

ROBERT P. RAPP, PHARMD, FCCP
CRAIG MARTIN, PHARMD
OCTOBER, 2008

DAVID G. FRAME, PHARMD
WILLIAM LESLIE, MD
OCTOBER, 2008

INSTITUTE FOR SAFE MEDICATION PRACTICES
OCTOBER, 2008

With an estimated 182,460 new cases and 40,480 related deaths in 2008, breast cancer remains the most common malignancy among US women and the second most lethal. During the 1980s, annual increases in the rate of breast cancer of approximately 3.7% were largely attributed to the widespread adoption of screening mammography.
OCTOBER, 2008

Colorectal cancer is the third leading cause of cancer deaths in men and women in the United States, with an estimated total of 49,960 deaths in 2008. The high number of deaths can be attributed to the inability to achieve cures in a substantial number of patients with metastatic disease.
AUGUST, 2008